UPDATE: Jefferies Upgrades Lincare Holdings; Risk-Reward Has Improved with Potential Takeout

Jefferies raises its rating on Lincare Holdings LNCR from Hold to Buy and raises its price target form $27 to $38. Jefferies comments, "Raising our rating on LNCR given our view that the company is now in play, whether or not the FT article -- which noted an ongoing sale process -- holds true. In the event that a deal for LNCR does not go through, we could see downside to $25, but we believe this pressure will be short-lived as mgmt will likely pursue an accretive acquisition fairly quickly (i.e., mgmt recently noted their interest in acquiring ROHI)." LNCR closed at $9.72 on Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorUpgradesPrice TargetPre-Market OutlookAnalyst RatingsHealth CareHealth Care ServicesJefferies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!